Results 261 to 270 of about 93,268 (298)

Tumor‐infiltrating lymphocytes in breast FNA biopsy cytology: A predictor of tumor‐infiltrating lymphocytes in histologic evaluation

Cancer Cytopathology, 2022
BackgroundTumor‐infiltrating lymphocytes (TILs) are associated with various clinicopathological features. Using cytologic specimens for assessing TILs remains to be established. This retrospective study aimed to establish a practical method to assess TILs in cytologic samples.MethodsThe authors found 1101 breast fine‐needle aspiration biopsy (FNAB ...
Toru Odate, Minh‐Khang Le, Masataka Kawai, Mizuki Kubota, Yohei Yamaguchi, Tetsuo Kondo   +5 more
openaire   +2 more sources

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy and Neoantigens

The Cancer Journal, 2017
The adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes has been shown to be effective at mediating tumor regression in more than half of patients with metastatic melanoma and in mediating long-term complete regression in approximately one fourth of all patients with this cancer.
openaire   +2 more sources

Tumor-infiltrating lymphocytes: A new hope

Cancer Cell
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2.
Amod A, Sarnaik, Patrick, Hwu, James J, Mulé, Shari, Pilon-Thomas   +3 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy

The Cancer Journal, 2015
Autologous adoptive T-cell therapies have made tremendous strides over the last few years with excitement currently being generated by technologies that can reprogram T-cell specificities toward any desired antigen including chimeric antigen receptors and recombinant T-cell receptors.
openaire   +2 more sources

Reporting Tumor Infiltrating Lymphocytes

2012
The presence of many tumor infiltrating lymphocytes (TILs) in primary cutaneous melanoma is associated with a better prognosis. The degree of lymphocytic interaction with the tumor cells is graded as “brisk”, “non-brisk” or “absent” as defined below:
Kasia Szyfelbein Masterpol, Andrea Primiani, Lyn McDivitt Duncan   +2 more
openaire   +1 more source

Predictors of Tumor-Infiltrating Lymphocyte Efficacy in Melanoma

Immunotherapy, 2015
In the past decades, the increasing knowledge in cellular immunology and tumor-host immune interactions, led to the development of immunotherapy approaches. Immunotherapy, based on adoptive cell transfer of ex vivo activated and expanded tumor-infiltrating T lymphocytes (TILs), has shown promising clinical results in patients with metastatic melanoma ...
Dragoslav, Zikich, Jacob, Schachter, Michal J, Besser   +2 more
openaire   +2 more sources

TUMOR INFILTRATING LYMPHOCYTES*

Annals of the New York Academy of Sciences, 1976
E, Klein, S, Becker, E, Svedmyr, M, Jondal, F, Vánky   +4 more
openaire   +2 more sources

Tumor-infiltrating lymphocytes

Critical Reviews in Oncology/Hematology, 1992
Theresa L. Whiteside, Lorenz M. Jost, Ronald B. Herberman   +2 more
openaire   +1 more source

Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients

Technology in Cancer Research and Treatment, 2021
Bing Yan
exaly